Certara, Inc. (NASDAQ:CERT) Receives $12.82 Average Price Target from Analysts

Certara, Inc. (NASDAQ:CERT) has received a consensus recommendation of “Moderate Buy” from the fifteen ratings firms that are currently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation, seven have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price target among brokerages that have covered the stock in the last year is $12.8182.

Several equities analysts have commented on the stock. Morgan Stanley dropped their price target on shares of Certara from $16.00 to $12.00 and set an “equal weight” rating for the company in a research note on Thursday, December 18th. Leerink Partners raised Certara from a “market perform” rating to an “outperform” rating and set a $13.00 target price for the company in a research note on Tuesday, January 6th. KeyCorp reduced their price target on Certara from $13.00 to $12.00 and set an “overweight” rating on the stock in a research report on Thursday, January 8th. Barclays lowered their price objective on Certara from $14.00 to $13.00 and set an “overweight” rating for the company in a research report on Monday, December 15th. Finally, BMO Capital Markets started coverage on shares of Certara in a report on Thursday, November 13th. They issued a “market perform” rating and a $9.00 target price on the stock.

Certara Stock Performance

NASDAQ CERT opened at $6.62 on Thursday. The company has a market cap of $1.05 billion, a P/E ratio of 94.57 and a beta of 1.47. Certara has a 1-year low of $6.45 and a 1-year high of $15.69. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.09 and a quick ratio of 2.09. The stock has a 50-day moving average of $8.82 and a two-hundred day moving average of $10.14.

Hedge Funds Weigh In On Certara

Several large investors have recently bought and sold shares of the business. Wasatch Advisors LP lifted its holdings in Certara by 28.6% during the 3rd quarter. Wasatch Advisors LP now owns 17,398,337 shares of the company’s stock worth $212,608,000 after buying an additional 3,865,455 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in Certara by 0.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 8,387,484 shares of the company’s stock worth $73,894,000 after purchasing an additional 35,203 shares during the last quarter. Deerfield Management Company L.P. boosted its holdings in Certara by 71.7% in the third quarter. Deerfield Management Company L.P. now owns 6,739,537 shares of the company’s stock valued at $82,357,000 after purchasing an additional 2,813,438 shares in the last quarter. Geneva Capital Management LLC boosted its holdings in Certara by 0.7% in the third quarter. Geneva Capital Management LLC now owns 6,160,754 shares of the company’s stock valued at $75,284,000 after purchasing an additional 45,859 shares in the last quarter. Finally, Teacher Retirement System of Texas increased its stake in Certara by 25.3% in the second quarter. Teacher Retirement System of Texas now owns 5,674,485 shares of the company’s stock valued at $66,391,000 after purchasing an additional 1,145,554 shares during the last quarter. Hedge funds and other institutional investors own 73.96% of the company’s stock.

About Certara

Certara is a biosimulation software and services company that partners with pharmaceutical, biotechnology and medical device developers to accelerate drug discovery, development and regulatory approval. The company’s platform integrates quantitative pharmacology, real-world evidence, artificial intelligence and machine learning to model and simulate drug behavior across a range of therapeutic areas and patient populations. By applying these mechanistic and data-driven approaches, Certara helps its clients predict clinical outcomes, optimize dosing strategies and streamline decision-making throughout the product lifecycle.

The company’s offerings are divided into software tools and consulting services.